| 6QU7: reference: The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies., Christian S, Merz C, Evans L, Gradl S, Seidel H, Friberg A, Eheim A, Lejeune P, Brzezinka K, Zimmermann K, Ferrara S, Meyer H, Lesche R, Stoeckigt D, Bauser M, Haegebarth A, Sykes DB, Scadden DT, Losman JA, Janzer A, Leukemia. 2019 Apr 2. pii: 10.1038/s41375-019-0461-5. doi:, 10.1038/s41375-019-0461-5. PMID: 30940908 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).